Fate Therapeutics (FATE) traded up 0.96 % during a 24 hours period ending at 07:33 PM Central Europe on Monday 26th. One Fate Therapeutics stock can currently be bought for about USD 2.06 on popular exchanges. Current supply of Fate Therapeutics stocks is 119.8 mn. Fate Therapeutics has a current market capitalization of USD 252.8 mn and approximately USD 2.3 mn worth of Fate Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Fate Therapeutics has traded -9.44 % down. Simple moving average of last 200 days is at USD 1.93. The highest price of past 52 weeks was recorded at USD 3.23 on 07/13/2026. 52 weeks low was at USD 0.95 on 12/23/2025.
Here is how related stocks have performed in the past 24 hours:
Sanara Medtech (SMTI) traded down -0.24 % and now trades at USD 32.91. Current market capitalisation for Sanara Medtech is USD 301.4 mn.
Benitec Biopharma (BNTC) traded down -1.93 % and now trades at USD 8.65. Current market capitalisation for Benitec Biopharma is USD 301.7 mn. Benitec Biopharma Limited will hold its 2026 Annual General Meeting on 24 November 2026. The hybrid session will take place in Melbourne and online, with shareholders able to vote by proxy or attendance. The agenda includes a presentation of the financial report for the year ended 30 June 2026, followed by several ordinary and special resolutions. Directors will seek approval to re‑elect Ms Sue MacLeaman and to confirm the appointments of Ms Maureen Baker and Mr Carl Stubbings as directors. Shareholders will also consider adopting the 2026 Employee Incentive Omnibus Plan, ratifying the issuance of previously granted options, and approving deferred shares for Director Dr David Atkins. A special resolution will seek shareholder approval for a 10 % placement facility, expanding the company’s ability to issue equity securities without further shareholder consent. All proposals are recommended by the board and the chair intends to vote in favour of the undirected proxies.
Montauk Renewables (MNTK) traded up 3.4 % and now trades at USD 2.13. Current market capitalisation for Montauk Renewables is USD 303.2 mn. Current price/earnings ratio for Montauk Renewables is 41.73.
Highview Merger (HVMC) traded up 0.1 % and now trades at USD 10.3. Current market capitalisation for Highview Merger is USD 302.6 mn.
Artiva Biotherapeutics (ARTV) traded down -0.81 % and now trades at USD 6.1. Current market capitalisation for Artiva Biotherapeutics is USD 300.7 mn.
About Fate Therapeutics
Fate Therapeutics, Inc. is a biotechnology service provider based in San Diego, United States. The company specializes in researching and developing therapies to repair and regenerate body tissues using stem cells. Fate Therapeutics conducts its business in the health care sector. The IPO of the company took place on Nasdaq on October 1st, 2013. The official website of the company is accessible under www.fatetherapeutics.com .
